<DOC>
	<DOCNO>NCT01418261</DOCNO>
	<brief_summary>The Symplicity HTN-3 study , multi-center , prospective , single-blind , randomize , control study safety effectiveness renal denervation subject uncontrolled hypertension . Bilateral renal denervation perform use Symplicity Catheter - percutaneous system delivers radiofrequency ( RF ) energy luminal surface renal artery .</brief_summary>
	<brief_title>SYMPLICITY HTN-3 Renal Denervation Patients With Uncontrolled Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Individual ≥ 18 ≤ 80 year old time randomization . Individual receive stable medication regimen include full tolerate dos 3 antihypertensive medication different class , one must diuretic ( change minimum 2 week prior screen ) expect maintain without change least 6 month . Individual office systolic blood pressure ( SBP ) ≥ 160 mmHg base average 3 blood pressure reading measure initial screen visit confirmatory screen visit Individual estimate glomerular filtration rate ( eGFR ) &lt; 45 mL/min/1.73 m2 Individual Ambulatory Blood Pressure Monitoring ( ABPM ) 24 hour average SBP &lt; 135 mmHg Individual type 1 diabetes mellitus Individual require chronic oxygen support mechanical ventilation ( e.g. , tracheostomy , CPAP , BiPAP ) nocturnal respiratory support sleep apnea . Individual primary pulmonary hypertension . Individual pregnant , nurse planning pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>uncontrolled hypertension</keyword>
	<keyword>renal denervation</keyword>
</DOC>